
Pasithea Therapeutics Corp. – NASDAQ:KTTAW
Pasithea Therapeutics Corp. stock price today
Pasithea Therapeutics Corp. stock price monthly change
Pasithea Therapeutics Corp. stock price quarterly change
Pasithea Therapeutics Corp. stock price yearly change
Pasithea Therapeutics Corp. key metrics
Market Cap | 3.21M |
Enterprise value | N/A |
P/E | -0.06 |
EV/Sales | -61.52 |
EV/EBITDA | 1.63 |
Price/Sales | 2.47 |
Price/Book | 0.02 |
PEG ratio | N/A |
EPS | -14.3 |
Revenue | N/A |
EBITDA | -16.43M |
Income | -16.28M |
Revenue Q/Q | N/A |
Revenue Y/Y | 106.45% |
Profit margin | -3536.23% |
Oper. margin | -3951.15% |
Gross margin | 72.51% |
EBIT margin | -3951.15% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePasithea Therapeutics Corp. stock price history
Pasithea Therapeutics Corp. stock forecast
Pasithea Therapeutics Corp. financial statements
Jun 2023 | 0 | -3.76M | |
---|---|---|---|
Sep 2023 | 0 | -3.61M | |
Dec 2023 | 976.30K | -5.04M | -517.07% |
Mar 2024 | 0 | -3.86M |
Jun 2023 | 38149391 | 2.55M | 6.71% |
---|---|---|---|
Sep 2023 | 30657411 | 2.28M | 7.45% |
Dec 2023 | 26116858 | 2.71M | 10.41% |
Mar 2024 | 22408099 | 2.52M | 11.27% |
Jun 2023 | -3.47M | 344.01K | -130.76K |
---|---|---|---|
Sep 2023 | -2.65M | 50.15K | -4.45M |
Dec 2023 | -3.31M | 54.53K | -16.89K |
Mar 2024 | -4.32M | 0 | 0 |
Pasithea Therapeutics Corp. alternative data
Aug 2023 | 1 |
---|---|
Sep 2023 | 1 |
Oct 2023 | 1 |
Nov 2023 | 1 |
Dec 2023 | 1 |
Jan 2024 | 15 |
Feb 2024 | 15 |
Mar 2024 | 15 |
Apr 2024 | 15 |
May 2024 | 8 |
Jun 2024 | 8 |
Jul 2024 | 8 |
Pasithea Therapeutics Corp. other data
Period | Buy | Sel |
---|---|---|
Aug 2022 | 233245 | 0 |
Sep 2022 | 153258 | 0 |
Oct 2022 | 1000 | 0 |
-
What's the price of Pasithea Therapeutics Corp. stock today?
One share of Pasithea Therapeutics Corp. stock can currently be purchased for approximately $0.02.
-
When is Pasithea Therapeutics Corp.'s next earnings date?
Unfortunately, Pasithea Therapeutics Corp.'s (KTTAW) next earnings date is currently unknown.
-
Does Pasithea Therapeutics Corp. pay dividends?
No, Pasithea Therapeutics Corp. does not pay dividends.
-
How much money does Pasithea Therapeutics Corp. make?
Pasithea Therapeutics Corp. has a market capitalization of 3.21M.
-
What is Pasithea Therapeutics Corp.'s stock symbol?
Pasithea Therapeutics Corp. is traded on the NASDAQ under the ticker symbol "KTTAW".
-
What is Pasithea Therapeutics Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Pasithea Therapeutics Corp.?
Shares of Pasithea Therapeutics Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Pasithea Therapeutics Corp. have?
As Jul 2024, Pasithea Therapeutics Corp. employs 8 workers, which is 47% less then previous quarter.
-
When Pasithea Therapeutics Corp. went public?
Pasithea Therapeutics Corp. is publicly traded company for more then 3 years since IPO on 15 Sep 2021.
-
What is Pasithea Therapeutics Corp.'s official website?
The official website for Pasithea Therapeutics Corp. is pasitheaclinics.com.
-
Where are Pasithea Therapeutics Corp.'s headquarters?
Pasithea Therapeutics Corp. is headquartered at 1111 Lincoln Road, Miami Beach, FL.
-
How can i contact Pasithea Therapeutics Corp.?
Pasithea Therapeutics Corp.'s mailing address is 1111 Lincoln Road, Miami Beach, FL and company can be reached via phone at +7 025144174.
Pasithea Therapeutics Corp. company profile:

Pasithea Therapeutics Corp.
pasitheaclinics.comNASDAQ
8
Biotechnology
Healthcare
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
Miami Beach, FL 33139
CIK: 0001841330
ISIN: US70261F1113
CUSIP: 70261F111